Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6920)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 14, 2014 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sedda S, Marafini I, Caruso R, Pallone F, Monteleone G. Proteinase activated-receptors-associated signaling in the control of gastric cancer. World J Gastroenterol 2014; 20(34): 11977-11984 [PMID: 25232234 DOI: 10.3748/wjg.v20.i34.11977] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v20/i34/11977.htm |
| Number | Citing Articles |
| 1 |
Marek Z. Wojtukiewicz, Dominika Hempel, Ewa Sierko, Stephanie C. Tucker, Kenneth V. Honn. Thrombin—unique coagulation system protein with multifaceted impacts on cancer and metastasis. Cancer and Metastasis Reviews 2016; 35(2): 213 doi: 10.1007/s10555-016-9626-0
|
| 2 |
John W Honour. New examples of antibody-based assay interferences. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2015; 52(3): 309 doi: 10.1177/0004563215580856
|
| 3 |
Michele Ammendola, Rosario Sacco, Valeria Zuccalà, Maria Luposella, Rosa Patruno, Pietro Gadaleta, Nicola Zizzo, Cosmo Gadaleta, Giovambattista De Sarro, Giuseppe Sammarco, Mihai Oltean, Girolamo Ranieri. Mast Cells Density Positive to Tryptase Correlate with Microvascular Density in both Primary Gastric Cancer Tissue and Loco-Regional Lymph Node Metastases from Patients That Have Undergone Radical Surgery. International Journal of Molecular Sciences 2016; 17(11): 1905 doi: 10.3390/ijms17111905
|
| 4 |
Xuan Liu, Jiahui Yu, Shangjin Song, Xiaoqiang Yue, Qi Li. Protease-activated receptor-1 (PAR-1): a promising molecular target for cancer. Oncotarget 2017; 8(63): 107334 doi: 10.18632/oncotarget.21015
|
| 5 |
Zhengye Shang, Zhiyuan Ma, Enqin Wu, Xingzhao Chen, Biguang Tuo, Taolang Li, Xuemei Liu. Effect of metabolic reprogramming on the immune microenvironment in gastric cancer. Biomedicine & Pharmacotherapy 2024; 170: 116030 doi: 10.1016/j.biopha.2023.116030
|
| 6 |
Nisha R. Pawar, Marguerite S. Buzza, Toni M. Antalis. Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2–Mediated Signaling: Co-Conspirators in Cancer Progression. Cancer Research 2019; 79(2): 301 doi: 10.1158/0008-5472.CAN-18-1745
|
| 7 |
Wataru Takaki, Hirotaka Konishi, Daiki Matsubara, Katsutoshi Shoda, Tomohiro Arita, Satoshi Kataoka, Jun Shibamoto, Hirotaka Furuke, Kazuya Takabatake, Hiroki Shimizu, Shuhei Komatsu, Atsushi Shiozaki, Takeshi Kubota, Kazuma Okamoto, Eigo Otsuji. Role of Extracellular High-Mobility Group Box-1 as a Therapeutic Target of Gastric Cancer. International Journal of Molecular Sciences 2022; 23(6): 3264 doi: 10.3390/ijms23063264
|
| 8 |
Marek Z. Wojtukiewicz, Dominika Hempel, Ewa Sierko, Stephanie C. Tucker, Kenneth V. Honn. Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis. Cancer and Metastasis Reviews 2015; 34(4): 775 doi: 10.1007/s10555-015-9599-4
|
| 9 |
Mirian A.F. Hayashi, Joana D. Campeiro, Camila M. Yonamine. Revisiting the potential of South American rattlesnake Crotalus durissus terrificus toxins as therapeutic, theranostic and/or biotechnological agents. Toxicon 2022; 206: 1 doi: 10.1016/j.toxicon.2021.12.005
|
| 10 |
Michele Ammendola, Rosario Sacco, Giuseppina Vescio, Valeria Zuccalà, Maria Luposella, Rosa Patruno, Nicola Zizzo, Claudia Gadaleta, Ilaria Marech, Roberta Ruggieri, Ibrahim Furkan Kocak, Taner Ozgurtas, Cosmo Damiano Gadaleta, Giuseppe Sammarco, Girolamo Ranieri. Tryptase mast cell density, protease-activated receptor-2 microvascular density, and classical microvascular density evaluation in gastric cancer patients undergoing surgery: possible translational relevance. Therapeutic Advances in Gastroenterology 2017; 10(4): 353 doi: 10.1177/1756283X16673981
|
| 11 |
Jia Zhao, Guangyu Jin, Xudong Liu, Kai Wu, Yang Yang, Zhanfeng He, Donglei Liu, Chunyang Zhang, Dengyan Zhu, Jia Jiao, Xiangnan Li, Song Zhao. PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02354-4
|
| 12 |
Hongshan Zhang, Ping Jiang, Chuanrao Zhang, Siman Lee, Wei Wang, Hao Zou. PAR4 overexpression promotes colorectal cancer cell proliferation and migration. Oncology Letters 2018; doi: 10.3892/ol.2018.9407
|
| 13 |
P. Gresele, S. Momi, M. Malvestiti, M. Sebastiano. Platelet-targeted pharmacologic treatments as anti-cancer therapy. Cancer and Metastasis Reviews 2017; 36(2): 331 doi: 10.1007/s10555-017-9679-8
|
| 14 |
Dalton Dittz Júnior, Fernanda de Oliveira Lemos, Ana Candida Araujo e Silva. Pathophysiological Aspects of Proteases. 2017; : 119 doi: 10.1007/978-981-10-6141-7_5
|
| 15 |
Ming Wang, Shanfa Ren, Zhun Bi, Liang Zhang, Mengqi Cui, Ronghao Sun, Jiali Bao, Dandi Gao, Bo Yang, Xiaoping Li, Mingjiang Li, Ting Xiao, Hong‐gang Zhou, Cheng Yang. Myricetin reverses epithelial–endothelial transition and inhibits vasculogenic mimicry and angiogenesis of hepatocellular carcinoma by directly targeting PAR1. Phytotherapy Research 2022; 36(4): 1807 doi: 10.1002/ptr.7427
|
| 16 |
Julie Brogaard Larsen, Anne-Mette Hvas. Thrombin: A Pivotal Player in Hemostasis and Beyond. Seminars in Thrombosis and Hemostasis 2021; 47(07): 759 doi: 10.1055/s-0041-1727116
|